Stay updated on Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe study record history now includes a new revision entry, v3.6.5, replacing the previous v3.6.4. This reflects an updated documentation version in the record history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page history now shows Revision: v3.6.4, replacing the previous v3.6.3. This indicates a minor internal update to the page's version information.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedNew revision tag v3.6.3 is added, replacing the previous v3.6.2 in the record history. This reflects a version update to the page rather than any substantive changes to study content.SummaryDifference0.1%

- Check48 days agoChange DetectedFooter revision badge updated from v3.6.0 to v3.6.2, indicating a minor software update to the ClinicalTrials.gov interface. This change does not affect the study data or navigation.SummaryDifference0.1%

- Check62 days agoChange DetectedThe record now indicates the study is Completed and recruitment is no longer active, signaling that participant enrollment and the trial activities have ended. Additionally, the page updates Study Design, Study Status, and Recruitment Status sections and notes revision to v3.6.0.SummaryDifference1%

- Check69 days agoChange DetectedA new revision entry v3.5.5 is added to the history and the previous v3.5.4 entry is removed, reflecting a minor update to the page's revision history metadata.SummaryDifference0.1%

Stay in the know with updates to Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial page.